About

Riccardo Lombardo is a leading urological surgeon and researcher whose work centers on robotic surgery, benign prostatic enlargement (BPE), and oncological outcomes for prostate and kidney cancers. His major contributions include defining the standard surgical approach for large-volume BPE through a systematic review of randomized trials (48 citations), and demonstrating that prostate-specific antigen density is a powerful predictor of tumor upstaging and upgrading under the new grading system (34 citations). Lombardo also developed the ROMe’s tool—a comprehensive nomogram for predicting long-term outcomes after robot-assisted partial nephrectomy for renal cell carcinoma (30 citations)—and has advanced the understanding of learning curves in robotic radical prostatectomy and cystectomy, identifying predictors of trainee proficiency (21 citations). His work on early continence recovery after robotic prostatectomy, correlating preserved urethral length with outcomes (6 citations), and his editorial on new robotic platforms (5 citations) underscore his influence. With over 200 total citations, Lombardo’s research bridges surgical technique, patient quality of life, and training optimization, making him a key figure in modern urology.

Research Focus

Key Achievements

8
H-Index
16
Papers
204
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
What is the standard surgical approach to large volume BPE? Systematic review of existing randomized clinical trials
48 citations · 2020
📈 Most Prolific Year: 2023 (4 Papers)
🤝 Key Collaborators: 132
🏛 Institutions: Casa di Cura Città di Roma, Sapienza University of Rome, Virginia Commonwealth University, Azienda Ospedaliera Sant'Andrea, CTO Andrea Alesini

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago